1. Organisation for Economic Co-operation and Development. Health at a Glance 2017. In: OECD Indicaors. OECD Publishing, Paris. 2017. https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2017_health_glance-2017-en. Accessed 28 Jun 2019.
2. Belloni A, Morgan D, Paris V. Pharmaceutical expenditure and policies: past trends and future challenges. OECD Health Working Paper No. 87. Paris: Organisation for Economic Co-operation and Development; 2016.
3. Organisation for Economic Co-operation and Development. Pharmaceutical innovation and access to medicines. In: OECD Health Policy Studies. OECD Publishing, Paris. 2018. https://www.oecd-ilibrary.org/content/publication/9789264307391-en. Accessed 28 Jun 2019.
4. Araujo FC, Goncalves J, Fonseca JE. Pharmacoeconomics of biosimilars: what is there to gain from them? Curr Rheumatol Rep. 2016;18(8):50. https://doi.org/10.1007/s11926-016-0601-0.
5. Haustein R, de Millas C, Hoer A, Haussler B. Saving money in the European healthcare systems with biosimilars. Generics Biosimilars Initiative J. 2012;1(3–4):120–6.